Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.
Stock data | 2024 | Change |
---|---|---|
Price | $0.00001 | N/A |
Market Cap | $0 | N/A |
Shares Outstanding | 0 | N/A |
Employees | 12.00 | N/A |